ABOUT THE CONFERENCE

As pharmaceutical and medical device corporations collect and utilize deeper volumes of data in order to elevate business decision making, leveraging analytics and big data sets to identify trends and provide deep statistical analysis, the role of data privacy throughout the entity has taken on new meaning. Further compounding the changes within this dynamic, data driven industry, regulatory authorities including the European Union have implemented new frameworks to support individual data privacy, including the General Data Privacy Regulation (GDPR) which has far reaching ramifications for all corporations working with European citizens. High profile data breaches as well as concerns surrounding individual data privacy with large multinational firms have thrust data privacy and privacy officers into a new light, along with additional resources to ensure standards are met.

From privacy by design and changing company culture in order to foster a common ground for data privacy to the appropriate processing of clinical subject, patient, employee and partner data in a protected and private manner to identification and erasure techniques, the changes facing today’s pharmaceutical and medical device corporations are immense. With tracked sessions focusing on GDPR which will highlight gap analysis and ensuring compliance standards have been met, to sessions focused on the next levels of GDPR alignment, this meeting will provide an unrivaled opportunity for life science data privacy officers. Blending the highest level of perspectives from both industry veterans as well as regulatory and legal authorities, the Q1 Data Privacy Governance and GDPR Alignment Conference will provide data privacy executives with the tools needed to maintain momentum following GDPR compliance dates, protecting company data and the privacy of partners across the organization.

CORE TOPICS TO BE ADDRESSED:

• Tracked sessions on alignment with GDPR compliance for advanced and intermediate privacy executives, focused on:
  • Conducting gap assessment to identify areas of potential concern in data privacy frameworks
  • Maintaining resources and momentum to ensure ongoing compliance with regulatory requirements
  • Group discussions at an intermediate level focused on current compliance concerns & interpretations
  • Small group dialogue for advanced executives focused on the future evolution of GDPR compliance
• Global data privacy concerns outside of EU GDPR including focus on evolving Chinese and Japanese requirements
• State breach notification requirements: Clarification surrounding notice processes & timelines for reporting
• Creating an internal culture focused on the importance of privacy to the ongoing success of life science corporations
• Opportunities for engaging staff in education and training focused on ensuring data privacy as a priority requirement
• Impact of cyber security concerns on data privacy, collaboration, internal readiness and security of private data
• Data privacy concerns related to global clinical studies, transfer of data, designation of parties & data consent
• Future of data privacy for the life science industry, challenge of regulations keeping pace with technological change
• Risk mitigation strategies when contracting with 3rd party vendors: CROs, software vendors & patient programs
• Big data privacy considerations in pharmaceutical & medical device research, development and data analytics
  • Data retention considerations for long-term data storage
  • Concerns surrounding international data portability
  • Use of data mapping and automation in life science
• Alignment between HIPAA security and GDPR as relevant to pharmaceutical and device manufacturers

ABOUT THE CONFERENCE

From privacy by design and changing company culture in order to foster a common ground for data privacy to the appropriate processing of clinical subject, patient, employee and partner data in a protected and private manner to identification and erasure techniques, the changes facing today’s pharmaceutical and medical device corporations are immense. With tracked sessions focusing on GDPR which will highlight gap analysis and ensuring compliance standards have been met, to sessions focused on the next levels of GDPR alignment, this meeting will provide an unrivaled opportunity for life science data privacy officers. Blending the highest level of perspectives from both industry veterans as well as regulatory and legal authorities, the Q1 Data Privacy Governance and GDPR Alignment Conference will provide data privacy executives with the tools needed to maintain momentum following GDPR compliance dates, protecting company data and the privacy of partners across the organization.